Navigation Links
KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
Date:8/28/2007

Technology to be Applied to Both Clinical- and Preclinical-Stage Compounds

in Merck KGaA Pipeline

EMERYVILLE, Calif., Aug. 28 /PRNewswire/ -- KineMed, Inc., a pathway-based drug discovery and development company, announced today that it will collaborate with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, to discover new applications for drug candidates. KineMed's proprietary pathway-based drug discovery and development technology identifies compounds that can modulate key metabolic pathways present in both preclinical animal models and in humans. By measuring real-time activity of drugs against these targeted pathways, KineMed's technology reduces development risk by selecting drug candidates with the best potential to demonstrate clinical efficacy and confirm desired drug activity in first-in-man studies.

In the collaboration, KineMed will identify new therapeutic utility in in vivo preclinical models by applying its proprietary translational medicine technologies. Once a disease target is established for a selected drug candidate, KineMed and Merck KGaA will jointly determine the best development and commercialization path for the development candidates being studied.

Under the terms of the agreement, KineMed will receive from Merck an upfront payment, milestones and royalty payments on products advanced with KineMed's technology. Additional terms of the deal were not disclosed.

David Fineman, President and CEO of KineMed, commented, "We are pleased to expand our relationship with Merck KGaA into this broader development collaboration. Our technology uniquely enables our partners to screen development candidates against KineMed's dynamic targets of pathway kinetics. Partnering with KineMed further enables its partners to rapidly demonstrate on-mechanism dose response in first-in-man studies with KineMed's unique translational medicine capabilities."

Mr. Fineman continued, "In this collabo
'/>"/>

SOURCE KineMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GE, St. Jude to collaborate on visualization technology
2. GE Healthcare, MobileAccess to collaborate on hospital wireless
3. GE Healthcare, Harvard medical school to collaborate on nervous system research
4. Madison, Milwaukee med schools to collaborate on tech transfer
5. EraGen collaborates with Emory University on HIV detection system
6. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
7. Silencer Validated siRNAs
8. Using Validated siRNAs in Functional Genomic Assays
9. YOUR DATA: Direct Real-time RT-PCR on Sympathetic Neuron Lysates Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs
10. YOUR DATA: Direct Real-time RT-PCR on Sympathetic Neuron Lysates Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs
11. Stem cell bank announcement validates quality of Wisconsin research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the ... Q3 orders to date to $5 million. The orders are ... . "We continue to see new orders coming ... these orders, our backlog has climbed to over $11 million." ... a leading clean technology company that designs, manufactures and distributes ...
(Date:9/23/2014)... September 23, 2014 This is ... Global and China Isopropanol (IPA) industry. The report ... definitions, applications and industry chain structure. Global market ... with a focus on history, developments, trends and ... the international and Chinese situation is also offered. ...
(Date:9/23/2014)... Texas Fertility Center (TFC) announces the opening ... a Central Texas footprint that includes Round Rock, Central ... for the region’s most established practice will provide full ... Buda, Kyle and San Marcos communities. , “We ... to individuals and couples living in and around South ...
(Date:9/23/2014)... Plymouth, MN (PRWEB) September 23, 2014 ... named NimbeLink, a developer of cellular modems ... a finalist in the Startup category for the ... will be held at the Minneapolis Convention Center ... Minnesota companies and individuals who have shown superior ...
Breaking Biology Technology:(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 3NimbeLink Named Finalist for 15th Annual Tekne Awards 2NimbeLink Named Finalist for 15th Annual Tekne Awards 3
... ,II. Product Components ,III. Materials to ... Extraction of DNA from Buccal Swab ,V. Protocol ... Quantification of Amplified Products ,VII. Purification of ... , References , Contact Information , , ,,Application ...
... , , ... , , , , ... individuals suffering,from cancer may serve as an,early indication that the primary,tumor ... individual,cancer cells may attach in distant,regions and form colonies as an,initial ...
... , , ... , , , ... Helicobacter,pylori (H. pylori) is the major,cause of chronic active gastritis,and ... studies using a,multiplex PCR (mPCR) based,approach distinguished different,allelic variants that ...
Cached Biology Technology:Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 2Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 3Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 4Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 5Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 6Sensitive detection of tumor cells in,peripheral blood of carcinoma patients,by a reverse transcription PCR method 2Sensitive detection of tumor cells in,peripheral blood of carcinoma patients,by a reverse transcription PCR method 3Sensitive detection of tumor cells in,peripheral blood of carcinoma patients,by a reverse transcription PCR method 4Sensitive detection of tumor cells in,peripheral blood of carcinoma patients,by a reverse transcription PCR method 5Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 2Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 3Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 4Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 5Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 6
(Date:9/23/2014)... CHAMPAIGN, Ill. Scientists have scoured cow rumens and ... plant cell walls for the production of next-generation biofuels, ... reside in the human lower intestine, researchers report. , ... of the National Academy of Sciences , is the ... that microbes in the human gut can digest fiber, ...
(Date:9/23/2014)... as good for your mental as your physical health, ... University of Warwick,s Medical School using data from the ... Open focused on mental wellbeing and found that ... an individual,s fruit and vegetable consumption. , 33.5% of ... portions of fruit and vegetables a day, compared with ...
(Date:9/23/2014)... humans, have parasitic DNA fragments called "jumping genes" that ... the process. And that phenomenon can result in age-related ... of Rochester now report that the "jumping genes" in ... multi-function protein stops keeping them in check in order ... study published today in Nature Communications , Professor ...
Breaking Biology News(10 mins):Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3Eating five a day may keep the blues away 2A multi-function protein is key to stopping genomic parasites from 'jumping' 2
... open-access journal PLoS Biology, streamlines the computation required to ... influence a particular physical trait, or phenotype. Thanks to ... Akey, and Leonid Kruglyak, researchers have a more efficient ... elements that produce specific traits. , In brewer's yeast ...
... Combining partially differentiated stem cells with gene therapy can promote ... damaged spinal cords of rats, a new study shows. The ... also improves the animals' motor function and electrical conduction from ... lead to new ways of treating spinal cord injury in ...
... a study conducted at Johns Hopkins show that stem cell ... myocardial infarction, in pigs. In just two months, stem cells ... animal's damaged heart restored heart function and repaired damaged heart ... findings, first presented last fall at the 2004 Scientific Sessions ...
Cached Biology News:Improved statistical tools reveal many linked loci 2Combination therapy leads to partial recovery from spinal cord injury in rats 2Combination therapy leads to partial recovery from spinal cord injury in rats 3Stem cell therapy successfully treats heart attack in animals 2
CBF-B (G-2)...
... B Receptor Like Protein 2 ... (ETBR-LP-2) has been reported in human ... human brain and colon libraries. ... the amino acid sequence is considered ...
HSV-2 gD (0191)...
... The epitope recognized by A300-183A ... isoform 5 of human quaking ... (GeneID 9444). The epitope ... 1, 2, 3, 4, 6, ...
Biology Products: